590 filings
Page 5 of 30
4/A
sqmrcc
21 Mar 22
9 METERS BIOPHARMA / Michael T. Constantino ownership change
4:17pm
4
rxfkoyrscndfe9m7xglo
7 Mar 22
9 METERS BIOPHARMA / Mark A Sirgo ownership change
8:01am
4
k1ci7p1rriny1wvot3m
4 Mar 22
9 METERS BIOPHARMA / John Temperato ownership change
8:00am
8-K
ji68b0gf49ds2c1k2
28 Feb 22
9 Meters Biopharma Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease
4:22pm
4
4witezuc4qlgukk
23 Feb 22
9 METERS BIOPHARMA / John Temperato ownership change
4:15pm
8-K
eam jxwkczfc5erae7dt
11 Feb 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
SC 13G/A
c5b7p05f09b0s8nc zn
10 Feb 22
9 METERS BIOPHARMA / ADAGE CAPITAL PARTNERS GP, L.L.C. ownership change
10:35am
SC 13G
dsglzm z9l1jgaut63
4 Feb 22
9 METERS BIOPHARMA / BlackRock ownership change
4:12pm
8-K
z9t1 dbcumny
24 Jan 22
9 Meters Biopharma Announces Allowance of Patent for NM-102 in Combination with Immune Checkpoint Inhibitors
8:06am
4
t3n12baok98wxlhz6t6
18 Jan 22
9 METERS BIOPHARMA / Bethany Sensenig ownership change
7:24pm
3
bih 6a9kk68hljofmgn
18 Jan 22
9 METERS BIOPHARMA / Bethany Sensenig ownership change
8:06am
8-K
hf1z4 lg5kfozq
18 Jan 22
9 Meters Biopharma Appoints Bethany Sensenig as Chief Financial Officer
8:05am
8-K
zkwtejg
3 Jan 22
Other Events
7:38am
4
b7gn44h
3 Dec 21
9 METERS BIOPHARMA / Mark A Sirgo ownership change
7:34am
4
75mtk60a7x48vczhg207
22 Nov 21
9 METERS BIOPHARMA / Mark A Sirgo ownership change
7:30am
4
zx0 b86z8
19 Nov 21
9 METERS BIOPHARMA / John Temperato ownership change
7:31am
8-K
icfgycxb6k889dv4i40t
15 Nov 21
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Third Quarter 2021
7:34am
8-K
1f2idk645shzq1v0 gr
10 Nov 21
9 Meters Biopharma, Inc. Announces Immuno-Oncology Collaboration with Gustave Roussy for NM-102, a Gut Microbiome Modulator
7:33am
8-K
nqnbjlfu4uq zy
26 Oct 21
2021 Annual Scientific Meeting
7:33am